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Comparison of long-pulsed alexandrite laser and topical 
tretinoin-ammonium lactate in axillary acanthosis 
nigricans: A case series of patients in a before-after trial 
 
 
Abstract 
Background: Acanthosis nigricans (AN) is a brown to black, velvety hyperpigmentation 
of the skin that usually involves cutaneous folds. Treatment of AN is important regarding 
cosmetic reasons and various therapeutic modalities have been used for these purposes. 
The goal of this study was to compare the effectiveness of long-pulsed alexandrite laser 
and topical tretinoin-ammonium lactate for treatment of axillary-AN. 
Methods: Fifteen patients with bilateral axillary-AN were studied in Razi Hospital, 
Tehran, Iran. Diagnosis was confirmed by two independent dermatologists. Each side skin 
lesion was randomly allocated to either topical mixed cream of tretinoin 0.05%- 
ammonium lactate 12% or long-pulsed alexandrite laser. Duration of treatment was 14 
weeks. At endpoint, the mean percent reduction from baseline in pigmentation area was 
compared between the two groups. 
Results: The study population consisted of 15 patients three males and 12, females. The 
mean age of patients was 28.5±4.9 years. The mean percent reduction was 18.3±10.6%, in 
tretinoin/ammonium lactate group and 25.7±11.8% in laser group (P=0.004). 
Conclusion: These findings indicate that the application of alexandrite laser is a relative 
effective method for treatment of axillary-AN. However, this issue requires further studies 
with prolonged follow-up period. 
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Acanthosis nigricans (A.N) is a cutaneous disorder characterized by brown to black, 
poorly circumscribed, velvety hyperpigmentation that is sometimes associated with 
hyperkeratotic plaques. It is usually found in cutaneous folds, such as posterior and lateral 
folds of the neck and the axilla (1-2). The exact prevalence of acanthosis nigricans is 
unknown but in few studies it has been estimated up to 7% in normal population (3). 
Acanthosis nigricans is much more common in people with darker skin, so that   in whites, 
the prevalence is less than 1% (4-5). Regarding histopathologic aspect, A.N is 
characterized by the thickening of the stratum corneum, ancanthosis, papillomatopsis, and 
minimal dermal involvement. Thickness of acanthosis is variable and usually minimal. In 
acanthosis nigricans, hyperkeratosis is a more common reason of dark color than the 
increased pigmentation. Sometimes in the lesion of A.N, there is secretion accumulation of 
lymphocytes, plasma cells and neutrophils, which can lead to horn pseudocyst formation.   
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Acanthosis nigricans can be associated with different 
kinds of syndromes, such as insulin resistance and mutation 
in fibroblast growth factor receptor. Although uncommon, 
but acanthosis nigricans may be induced by several 
medications such as corticosteroids, niacin, insulin, oral 
contraceptives and protease inhibitors (6-8). The goal of 
therapy in acanthosis nigricans is to correct the underlying 
disorder and treatment of lesion of acanthosis nigricans 
mainly is due to cosmetic reasons. Topical medications with 
some therapeutic success have been used for acanthosis 
nigricans, including: topical retinoids and lactates (9), topical 
vitamin A (10), and topical keratolytics (11). Cryotherapy is 
another method treatment in acanthosis nigricans using 
liquid nitrogen, and its efficacy depends on several factors, 
including; depth of the lesion, amount of lesions vascularity, 
duration of each freezing cycle and number of performed 
freezing cycles. The side effects most commonly 
encountered with this type of treatment are 
hypopigmentation and local recurrences (12). Curettage, 
simple excision, electrodessication and dermabrasion are the 
other treatment modalities.  
Pulsed dye laser (PDL) showed low efficacy in the 
treatment of acanthosis nigricans due to its low energy and 
low penetration of laser beams. Alexandrite laser with 755 
nm wave length can target melanin pigments in 
keratinocytes; therefore, it is capable to destruct melanin 
containing keratinocytes. Alexandrite laser has a high 
penetration rate and able to destroy AN lesions without any 
damage to surrounding tissues (13-15). The efficacy of long-
pulsed alexandrite laser has been demonstrated for the 
treatment of many pigmented lesions including axillary-
acanthosis nigricans until now, although there is a high 
prevalence of acanthosis nigricans and its interfering 
cosmetic problems, no treatment of any choice has been 
proposed with this regard. We decided to evaluate the 
efficacy of alexandrite laser in the treatment of acanthosis 
nigricans and compare its cosmetic results with other routine 
topical peeling agent which was a mixed cream of tretinoin 
and ammonium lactate.  
 
 
Methods 
The study population comprised 15 cases of AN which 
was conducted in Razi Hospital, Tehran, Iran in 2012. This 
was an assessor and analyst-blinded, randomized, controlled 
before-after clinical trial study.  The study participants were 
recruited among these subjects with AN in the axillary 
regions. The diagnosis was confirmed clinically by two 
dermatologists. 
Criteria for inclusion were: presence of  bilateral axillary- 
acanthosis nigricans , normal laboratory test regarding blood 
sugar, hormonal profile and liver function tests, no history of 
any medication consumption  which was considered as drug-
related cause of acanthosis nigricans such as nicotinic acid, 
fusidic acid and oral contraceptives, no underlying 
malignancy, not pregnant, no skin disorders localized to the 
treated area such as vitiligo (due to Koebner phenomenon), 
no history of taking oral retinoids in the last six months (due 
to contra-indication in laser therapy). Based on an earlier 
study (16-18), a 20% or greater improvement in skin lesions 
compared to baseline values was considered as treatment 
response. With regard to type I error of 5% and the study 
power of 80%, the minimum sample size required in each 
group was 15 patients.  
According to the study design, one side axillary-
acanthosis nigricans was treated with laser while the contra 
lateral side with topical tretinoin 0.05%/ammonium lactate 
12%. After the ethics approval of the committee, 15 patients 
were enrolled into the study after explaining the complete 
information about the aims of the study, likewise filling out 
the informed consent form, sequencing performed-based on 
balanced block randomization, as well as evaluating 15 
binary sites (right and left side for each patient, totally 30 
sites).  Each side of axilary region was allocated randomly to 
laser therapy or treatment with tretinoin 0.05%/ 
ammoniumlactate 12%. 
Combination of tretinoin 0.05% and ammonium lactate 
12% was used every other night, and long-pulsed alexandrite 
laser for the opposite side was repeated every 3 weeks. Four 
laser shot with 18 mm spot size and energy of 20 mJ also 
DCD off as a 2×2 cm2, were considered for therapy. Changes 
in response to treatment were determined by the comparison 
of photographs taken at baseline and treatment duration for 
each patient was 14 weeks, and each patient received 5 
sessions of laser with 3 weeks interval. At the end of this 
therapy course and after 1 week interval (for relieving the 
local skin reactions and irritations), both side lesions were 
photographed again and was assessed by a blinded expert 
dermatologist (the assessor of study who did not know the 
type of intervention used for each side axillary-acanthosis 
nigricans). The assessor determined the pigmentation 
reduction percent after therapy, based on visual analogue 
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scale (VAS). The data were finally analyzed by a blind 
researcher.  
For data analysis, SPSS software Version 22 was used. 
Descriptive tests (such as mean, median and standard 
deviation) were performed for qualitative variables and 
analytic tests (such as t-test, ANOVA) for quantitative ones. 
A p-value under 0.05 was considered as statistically 
significant. 
 
Results 
Fifteen patients including 3 men and 12 women were 
enrolled into the study. The mean age of the patients was 
28.5±4.9 years ranging from 18 to 37 years .The mean 
percent reduction in the pigmentation after laser therapy was 
25.67±11.78 (ranging from 15 to 50 percent) and 
18.33±10.63 (ranging from 10 to 50 percent). by topical 
therapy. The difference was statistically different (P=0.004) 
(table 1). 
Table 1. Mean amount of pigmentation reduction in two treatment groups of axillary-acanthosis nigricans 
 
Treatment method Mean reduction in 
pigmentation (%) 
Least amount of decrease 
in pigmentation(%) 
Maximum amount of  
decrease in pigmentation(%) 
P-value 
Laser therapy 25.67±11.78 15 50 0.004 
Topical tretinoin 0.05% ammonium 
lactate 12% 
18.33±10.63 10 50  
 
Discussion 
The findings of this study indicated significantly higher 
efficacy of laser therapy versus topical treatment of AN. 
Pigmented cutaneous lesions form a major part of problems 
encountered in skin-related disorders. Among the pigmented 
lesions, acanthosis nigricans is somehow unique due to 
needing to long-term therapies with peeling agents and also 
topical retinoids. But the treatment results are not generally 
satisfactory. With regard to the high prevalence of acanthosis 
nigricans, particularly in overweight patients and lack of any 
effective treatments, identification of new treatment 
modalities seems to be necessary and worthwhile (1-5). 
According to this study, the mean age of the patients was 
less than 30 years old. In this age group, the psychological 
burden of acanthosis negricans on quality of life is 
important.  
Although none of the treatment modality resulted in 
complete recovery of skin lesion, but reduction in 
pigmentation was significantly higher in the alexandrite laser 
treatment group rather than the topical tertinoin/ammonium 
lactate group. The efficacy of long-pulsed alexandrite laser 
has been shown also in other similar studies, for example, 
Rosenbach in 2002 found that alexandrite laser had 
acceptable results in the treatment of acanthosis nigricans 
with low level of therapy-related complications (16). In 
addition, this author in another study proved a 95% 
improvement in acanthosis nigricans lesions after 7 sessions 
of laser therapy without recurrences in a 2 -year follow-up 
(17). 
 
In conclusion, the results of this study indicates that using 
long-pulsed alexandrite laser can effectively and safely treat 
axillary-acanthosis nigricans, which exerts greater beneficial 
effect than routine topical peeling agents. The results of this 
study should be considered with limitations as regard low 
sample size. In addition, in the present study, the mean 
changes in pigmentation area was considered as the main 
variable, whereas, further treatment is expected to influence 
on the thickness of lesions as well as the total cosmetic 
result. Long term treatment and follow-up is expected to 
show greater efficacy. This context requires further studies. 
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